Predictive clinical ‐genetic model of long‐term non‐response to tumor necrosis factor‐alpha inhibitor therapy in spondyloarthritis

ConclusionWe developed a clinical ‐genetic model to identify SpA patients with a long‐term non‐response to TNFi therapy.

Source: International Journal of Rheumatic Diseases - May 21, 2019 Category: Rheumatology Authors: Jessica Polo y La Borda, Jos é Campos, Jesús Sanz, José Luis Andréu, Juan Mulero, Alejandra Sánchez Tags: ORIGINAL ARTICLE Source Type: research